Trial of Endostar Combined With CHOPT for T Cell Lymphoma

NCT01430013 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

T Cell Lymphoma

Interventions

DRUG: Endostar and CHOPT

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Collaborators

[object Object]